Digestion Aids Market to Reach $28.96 Billion by 2035
Digestion Aids market was valued at $19.25 billion in 2025 and is expected to reach $28.96 billion by 2035, registering a CAGR of 4.2% during the forecast period from 2026 to 2035. The market is being driven by a substantial increase in the prevalence of functional gastrointestinal conditions, which creates expanding demand for targeted digestive health products such as probiotics, digestive enzymes, fiber supplements, and OTC antacids. Functional gastrointestinal disorders, including irritable bowel syndrome (IBS), affect a significant proportion of the global population, with updated systematic analyses showing that IBS prevalence ranges between approximately 11–17% globally when using standard diagnostic criteria. This high and growing prevalence reflects a persistent unmet need for preventive and symptomatic digestive support, prompting greater consumer adoption of digestion aids. Healthcare professionals and public health bodies are increasingly recognizing the role of lifestyle, diet, and gut microbiota in managing these conditions, reinforcing product relevance. The result is stronger consumption patterns across retail pharmacy, e?commerce, and modern trade channels, underpinned by evolving clinical and consumer awareness.
Browse the full report description of “Digestion Aids Market Size, Share & Trends Analysis Report by Product Type (Prebiotics, Probiotics, Digestive Enzymes, Fiber-based Supplements, and Antacids & Acid Neutralizers (OTC)), by Formulation (Tablets, Capsules, Powders, Liquids, Gummies), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, and Supermarkets & Hypermarkets), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/digestion-aids-market
The sustained increase in functional gastrointestinal disorders is corroborated by health organisation data indicating a broad impact across regions, with community?based surveys reporting that up to 49% of females and 36.6% of males meet criteria for at least one functional GI condition, including IBS and functional constipation, underscoring a substantial addressable population for digestion aids manufacturers. This epidemiological context supports the market’s growth trajectory by highlighting a large base of individuals seeking symptom relief and gut health maintenance. As a result, demand for scientifically positioned digestive supplements, enhanced formulations, and accessible delivery formats continues to expand, reflecting the market’s responsiveness to evolving health burdens.
Market Coverage
- The market number available for – 2025-2035
- Base year- 2025
- Forecast period- 2026-2035
- Segment Covered-
- Product Type
- Formulation
- Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape – Amway Corp., Bayer AG, Danone S.A., Nestlé S.A., and Yakult Honsha Co., Ltd., among others.
Key questions addressed by the report.
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Digestion Aids Market Report Segment
By Product Type
- Prebiotics
- Probiotics
- Digestive Enzymes
- Fiber-based Supplements
- Antacids & Acid Neutralizers (OTC)
By Formulation
- Tablets
- Capsules
- Powders
- Liquids
- Gummies
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Supermarkets & Hypermarkets
Global Digestion Aids Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia and New Zealand
- ASEAN Economies
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digestion-aids-market